ARHGAP30 and lung carcinoma: However, ARHGAP30 has been relatively well studied in different cancers, for example, ARHGAP30 inhibited the proliferation, migration and invasion of lung cancer cells42 and pancreatic cancer43 by inhibiting the Wnt/β‐catenin signalling pathway.